Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Tongue Neoplasms 1Thymoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Endometrial Stromal 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Fibrosarcoma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Dermatofibrosarcoma 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Bone Neoplasms 1Bone Diseases 1

Interventions

Doxorubicin 5pazopanib 4Ifosfamide 3pembrolizumab 2Sunitinib 2Radiotherapy, Conformal 2Radiotherapy 2tremelimumab 1temsirolimus 1sintilimab 1saracatinib 1sapanisertib 1romidepsin 1olaratumab 1liposomal doxorubicin 1indolepropanol phosphate 1eribulin 1durvalumab 1Watchful Waiting 1Surgical Procedures, Operative 1Sorafenib 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiation 1Polymerase Chain Reaction 1Observation 1Nivolumab 1Neoadjuvant Therapy 1Methotrexate 1MLN 8237 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Histiocytoma, Malignant Fibrous × saracatinib × Clear all
NCT00659360 2018-06-29

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
17 enrolled 9 charts
GynecologicSarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡